[Hong Kong, 4 March 2016]  Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.

Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare.   Mr Liu’s area of focus is commercialisation and M&A.  He has extensive experience in healthcare big data and healthcare technologies.

Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr  Ha Yung-kuen have also been re-appointed for another two-year term.

Related News

Delegation from Shenzhen Stock Exchange visits ASTRI

A delegation from the Shenzhen Stock Exchange visited ASTRI on 19 April 2018, led by Mr Liu Fuzhong ...

Guangzhou Port Co Ltd Delegation Visits ASTRI

A group of 25 senior management staff from the Guangzhou Port Company Limited who participated in a ...

Financial Secretary visits ASTRI and reiterates his resolve to drive development and growth powered by technology

Mr Paul Chan Mo-po, Financial Secretary (FS) of the HKSAR Government, visited ASTRI today (18 April ...

2018-19 budget looks to invest in innovation and technology to secure a strong future for Hong Kong: Financial Secretary visits ASTRI and reiterates his resolve to drive development and growth powered by technology

On 28 February 2018, Mr Paul Chan, Financial Secretary (FS) of the HKSAR Government, delivered Hong ...

Showcasing how it powers Smart City development endeavours with innovation and technology, ASTRI interacts with a large, enthusiastic crowd at the International ICT Expo 2018

ASTRI was present in the International ICT Expo 2018 – organised by Hong Kong Trade Development Coun ...